Aldeyra Therapeutics Inc
XBER:137
Aldeyra Therapeutics Inc
XBER:137
Price:
4.419
EUR
Market Closed
Market Cap:
€475.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aldeyra Therapeutics Inc
XBER:137
|
US |
|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
US |
|
Immunovant Inc
NASDAQ:IMVT
|
US |
|
B
|
Banca Sistema SpA
SWB:B2S
|
IT |
|
O
|
Ovid Therapeutics Inc
F:1OT
|
US |
|
G
|
Gilat Satellite Networks Ltd
F:GSA
|
IL |
|
L
|
Lucky Cement Ltd
KAR:LUCK
|
PK |
|
M
|
Mari Energies Ltd
KAR:MARI
|
PK |
|
Linedata Services SA
PAR:LIN
|
FR |
|
Nedap NV
OTC:NDDLF
|
NL |
|
L
|
Lixil Corp
F:TJS
|
JP |
|
A
|
Apple Inc
XHAN:APC
|
US |
Wall St Price Targets
Price Targets Summary
Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc
Wall Street analysts forecast Aldeyra Therapeutics Inc stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for Aldeyra Therapeutics Inc is 20.283 EUR with a low forecast of 5.579 EUR and a high forecast of 37.7 EUR.
Lowest Forecast
Price Target
5.579
EUR
26% Upside
Average Forecast
Price Target
20.283
EUR
359% Upside
Highest Forecast
Price Target
37.7
EUR
753% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Aldeyra Therapeutics Inc's stock price target?
Price Target
20.283
EUR
20.283
EUR
According to Wall Street analysts, the average 1-year price target for Aldeyra Therapeutics Inc is 20.283 EUR with a low forecast of 5.579 EUR and a high forecast of 37.7 EUR.
